News
-
-
PRESS RELEASE
EQS-Adhoc: Deutsche Börse AG: Deutsche Börse AG and Allfunds Group plc reached an agreement on recommended acquisition by Deutsche Börse AG of Allfunds Group plc
Deutsche Börse AG and Allfunds Group plc have agreed on a recommended acquisition by Deutsche Börse AG of Allfunds Group plc, valuing Allfunds at €5.3 billion -
-
-
PRESS RELEASE
H1 2026 revenues up 15.4% compared to H1 2025 Four additional power generation units in Hauts-de-France to start up shortly, following the signing of the Gaz de Mines agreement Investment program in Norway continues
La Française de l'Énergie reports 15.4% revenue growth in H1 2026 compared to H1 2025. Expansion of power generation in Hauts-de-France and investment in Norway -
PRESS RELEASE
AB Science receives Japanese patent protection for the use of masitinib in progressive forms of multiple sclerosis (MS) until 2041
AB Science receives Japanese patent protection for the use of masitinib in progressive forms of multiple sclerosis (MS) until 2041, positioning it uniquely and competitively in the treatment landscape -
PRESS RELEASE
OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101)
OSE Immunotherapeutics acknowledges FDA Orphan Drug Designation granted to pegrizeprument (VEL-101) for organ rejection prevention in liver transplant patients. Veloxis Pharmaceuticals to develop and commercialize the product globally -
-
-
